Public Market

IPO

Mankind Pharma plans $1-B IPO, hires bankers

Economic Times  

Delhi-based Mankind Pharma has hired merchant bankers for a USD 900 million - USD 1 billion (USD 7,600 crore) IPO. In the proposed offer for sale component, existing investor ChrysCapital will sell an about 1% stake, Capital International will sell another 6% while the promoter Juneja family will sell 3%. The offer will value the company at about USD 8-9 billion (INR 61,000 crore). A ChrysCapital-led consortium (including GIC of Singapore and CPP Investments) owns 10% of Mankind, while Capital International owns 11%.